ArticleFrontiers in pediatrics2025
Advancing risk factor identification for pediatric lobar pneumonia: the promise of machine learning technologies.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Predictive value of bronchoalveolar lavage fluid leukotriene C4 for airway hyperresponsiveness in children withTranslational pediatrics · 2026Article
- Machine learning-based identification of inflammatory biomarkers for predicting pulmonary consolidation in children with Chlamydia pneumoniae infection.Frontiers in pediatrics · 2026Article
- A potential XGBoost Diagnostic Score forFrontiers in immunology · 2025Article
- Integrated nursing and medical management improves outcomes in pediatric lobar pneumonia: a randomized controlled study.Frontiers in pediatrics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Community-acquired pneumonia (CAP) is a prevalent pediatric condition, and lobar pneumonia (LP) is considered a severe subtype. Early identification of LP is crucial for appropriate management. This study aimed to develop and compare machine learning models to predict LP in children with CAP. Methods: A total of 25 clinical and laboratory variables were collected. Missing data (<2%) were imputed, and the dataset was split into training (60%) and validation (40%) sets. Univariable logistic regression and Boruta feature selection were used to identify significant predictors. Four machine learning algorithms-Logistic Regression (LR), Support Vector Machine (SVM), Extreme Gradient Boosting (XGBoost), and Decision Tree (DT)-were compared using area under the curve (AUC), balanced accuracy, sensitivity, specificity, and F1 score. SHAP analysis was performed to interpret the best-performing model. Results: A total of 278 patients with CAP were included in this study, of whom 65 were diagnosed with LP. The XGBoost model demonstrated the best performance with an AUC of 0.880 (95% CI: 0.807-0.934) in the training set and 0.746 (95% CI: 0.664-0.843) in the validation set. SHAP analysis identified age, CRP, CD64 index, lymphocyte percentage, and ALB as the top five predictive factors. Conclusion: The XGBoost model showed superior performance in predicting LP in children with CAP. The model enabled early diagnosis and risk assessment of LP, thereby facilitating appropriate clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.